Browsing by Author Patsouris, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 11 of 11
TitleAuthor(s)Issue date
The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancerVairaktaris, E.; Yapijakis, C.; Nkenke, E.; Vassiliou, S.; Vylliotis, A.; Nixon, A. M.; Derka, S.; Ragos, V.; Spyridonidou, S.; Tsigris, C.; Neukam, F. W.; Patsouris, E.24-Nov-2015
Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancerVairaktaris, E.; Yapijakis, C.; Vylliotis, A.; Derka, S.; Vassiliou, S.; Nkenke, E.; Serefoglou, Z.; Ragos, V.; Critselis, E.; Avgoustidis, D.; Neukam, F.; Patsouris, E.24-Nov-2015
Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancerVairaktaris, E.; Yapijakis, C.; Vasiliou, S.; Derka, S.; Nkenke, E.; Serefoglou, Z.; Vorris, E.; Vylliotis, A.; Ragos, V.; Neukam, F. W.; Patsouris, E.24-Nov-2015
Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancerVairaktaris, E.; Yapijakis, C.; Tsigris, C.; Vassiliou, S.; Derka, S.; Nkenke, E.; Spyridonidou, S.; Vylliotis, A.; Vorris, E.; Ragos, V.; Neukam, F. W.; Patsouris, E.24-Nov-2015
Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinomaVairaktaris, E.; Yapijakis, C.; Derka, S.; Serefoglou, Z.; Vassiliou, S.; Nkenke, E.; Ragos, V.; Vylliotis, A.; Spyridonidou, S.; Tsigris, C.; Yannopoulos, A.; Tesseromatis, C.; Neukam, F. W.; Patsouris, E.24-Nov-2015
FGFR-2 and -3 play an important role in initial stages of oral oncogenesisVairaktaris, E.; Ragos, V.; Yapijakis, C.; Derka, S.; Vassiliou, S.; Nkenke, E.; Yannopoulos, A.; Spyridonidou, S.; Vylliotis, A.; Papakosta, V.; Loukeri, S.; Lazaris, A.; Tesseromatis, C.; Tsigris, C.; Patsouris, E.24-Nov-2015
Hypoxemic reperfusion after 120 mins of intestinal ischemia attenuates the histopathologic and inflammatory responseDouzinas, E. E.; Kollias, S.; Tiniakos, D.; Evangelou, E.; Papalois, A.; Rapidis, A. D.; Tsoukalas, G. D.; Patsouris, E.; Roussos, C.24-Nov-2015
Increased risk of oral cancer in diabetic animals is not associated with c-jun activation pathwayVairaktaris, E.; Goutzanis, L.; Kalokerinos, G.; Vassiliou, S.; Spyridonidou, S.; Avgoustidis, D.; Strantzias, P.; Lazaris, A.; Papageorgiou, G.; Ragos, V.; Yapijakis, C.; Patsouris, E.24-Nov-2015
The interleukin-1 beta gene polymorphism +3953 C/T is not associated with risk for oral cancerVairaktaris, E.; Serefoglou, Z.; Yapijakis, C.; Stathopoulos, P.; Vassiliou, S.; Derka, S.; Nkenke, E.; Vylliotis, A.; Ragos, V.; Neukam, F. W.; Patsouris, E.24-Nov-2015
Myocardial ischemia in intestinal postischemic shock: the effect of hypoxemic reperfusionDouzinas, E. E.; Pitaridis, M. T.; Patsouris, E.; Kollias, S.; Boursinos, V.; Karmpaliotis, D. I.; Gratsias, Y.; Evangelou, E.; Papalois, A.; Konstantinidou, A. E.; Roussos, C.24-Nov-2015
Strong association of interleukin-6 -174 G>C promoter polymorphism with increased risk of oral cancerVairaktaris, E.; Yiannopoulos, A.; Vylliotis, A.; Yapijakis, C.; Derka, S.; Vassiliou, S.; Nkenke, E.; Serefoglou, Z.; Ragos, V.; Tsigris, C.; Vorris, E.; Critselis, E.; Avgoustidis, D.; Neukam, F. W.; Patsouris, E.24-Nov-2015